{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T04:57:09Z","timestamp":1794459429344,"version":"4.9.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100008730","name":"Kreftforeningen","doi-asserted-by":"publisher","award":["216129-2020"],"award-info":[{"award-number":["216129-2020"]}],"id":[{"id":"10.13039\/100008730","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Norwegian Esophageal Cancer Consortium","award":["220115-2020"],"award-info":[{"award-number":["220115-2020"]}]},{"DOI":"10.13039\/501100006095","name":"Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","award":["2024032"],"award-info":[{"award-number":["2024032"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005366","name":"University of Oslo","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005366","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"DOI":"10.1186\/s13148-025-01901-4","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T04:22:09Z","timestamp":1749010929000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Comparison of enzymatic and bisulfite conversion of circulating cell-free tumor DNA for DNA methylation analyses"],"prefix":"10.1186","volume":"17","author":[{"given":"Stine H.","family":"Kresse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evy Marie","family":"Thorkildsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Brandt-Winge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Pharo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hege Marie","family":"Vedeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guro E.","family":"Lind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"key":"1901_CR1","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.tig.2021.05.002","volume":"37","author":"A Nishiyama","year":"2021","unstructured":"Nishiyama A, Nakanishi M. Navigating the DNA methylation landscape of cancer. Trends Genet. 2021;37:1012\u201327.","journal-title":"Trends Genet"},{"key":"1901_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btac766","author":"M Jeanmougin","year":"2023","unstructured":"Jeanmougin M, Brodal HP, Pharo HD, Vedeld HM, Lind GE. PoDCall: positive droplet calling and normalization of droplet digital PCR DNA methylation data. Bioinformatics. 2023. https:\/\/doi.org\/10.1093\/bioinformatics\/btac766.","journal-title":"Bioinformatics"},{"key":"1901_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13148-018-0456-5","volume":"10","author":"HD Pharo","year":"2018","unstructured":"Pharo HD, Andresen K, Berg KCG, Lothe RA, Jeanmougin M, Lind GE. A robust internal control for high-precision DNA methylation analyses by droplet digital PCR. Clin Epigenetics. 2018;10:24.","journal-title":"Clin Epigenetics"},{"issue":"12","key":"1901_CR4","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.3390\/biom10121677","volume":"10","author":"F Galardi","year":"2020","unstructured":"Galardi F, De Luca F, Romagnoli D, Biagioni C, Moretti E, Biganzoli L, Di Leo A, Migliaccio I, Malorni L, Benelli M. Cell-Free DNA-methylation-based methods and applications in oncology. Biomolecules. 2020;10(12):1677. https:\/\/doi.org\/10.3390\/biom10121677.","journal-title":"Biomolecules"},{"key":"1901_CR5","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1016\/j.bmcl.2007.01.040","volume":"17","author":"K Tanaka","year":"2007","unstructured":"Tanaka K, Okamoto A. Degradation of DNA by bisulfite treatment. Bioorg Med Chem Lett. 2007;17:1912\u20135.","journal-title":"Bioorg Med Chem Lett"},{"key":"1901_CR6","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1101\/gr.265306.120","volume":"31","author":"Z Sun","year":"2021","unstructured":"Sun Z, Vaisvila R, Hussong LM, Yan B, Baum C, Saleh L, Samaranayake M, Guan S, Dai N, Correa IR Jr, et al. Nondestructive enzymatic deamination enables single-molecule long-read amplicon sequencing for the determination of 5-methylcytosine and 5-hydroxymethylcytosine at single-base resolution. Genome Res. 2021;31:291\u2013300.","journal-title":"Genome Res"},{"key":"1901_CR7","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1101\/gr.266551.120","volume":"31","author":"R Vaisvila","year":"2021","unstructured":"Vaisvila R, Ponnaluri VKC, Sun Z, Langhorst BW, Saleh L, Guan S, Dai N, Campbell MA, Sexton BS, Marks K, et al. Enzymatic methyl sequencing detects DNA methylation at single-base resolution from picograms of DNA. Genome Res. 2021;31:1280\u20139.","journal-title":"Genome Res"},{"key":"1901_CR8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13148-022-01420-6","volume":"15","author":"P Guo","year":"2023","unstructured":"Guo P, Zheng H, Li Y, Li Y, Xiao Y, Zheng J, Zhu X, Xu H, He Z, Zhang Q, et al. Hepatocellular carcinoma detection via targeted enzymatic methyl sequencing of plasma cell-free DNA. Clin Epigenetics. 2023;15:2.","journal-title":"Clin Epigenetics"},{"key":"1901_CR9","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1038\/s41598-024-52114-3","volume":"14","author":"JN Hubert","year":"2024","unstructured":"Hubert JN, Iannuccelli N, Cabau C, Jacomet E, Billon Y, Serre RF, Vandecasteele C, Donnadieu C, Demars J. Detection of DNA methylation signatures through the lens of genomic imprinting. Sci Rep. 2024;14:1694.","journal-title":"Sci Rep"},{"key":"1901_CR10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13072-021-00401-y","volume":"14","author":"J Morrison","year":"2021","unstructured":"Morrison J, Koeman JM, Johnson BK, Foy KK, Beddows I, Zhou W, Chesla DW, Rossell LL, Siegwald EJ, Adams M, et al. Evaluation of whole-genome DNA methylation sequencing library preparation protocols. Epigenetics Chromatin. 2021;14:28.","journal-title":"Epigenetics Chromatin"},{"key":"1901_CR11","doi-asserted-by":"publisher","first-page":"1037342","DOI":"10.3389\/fonc.2023.1037342","volume":"13","author":"EM Trinidad","year":"2023","unstructured":"Trinidad EM, Juan-Ribelles A, Pisano G, Castel V, Canete A, Gut M, Heath S, Font de Mora J. Evaluation of circulating tumor DNA by electropherogram analysis and methylome profiling in high-risk neuroblastomas. Front Oncol. 2023;13:1037342.","journal-title":"Front Oncol"},{"key":"1901_CR12","doi-asserted-by":"publisher","first-page":"14797","DOI":"10.1038\/s41598-024-63411-2","volume":"14","author":"M Kim","year":"2024","unstructured":"Kim M, Park J, Seonghee O, Jeong BH, Byun Y, Shin SH, Im Y, Cho JH, Cho EH. Deep learning model integrating cfDNA methylation and fragment size profiles for lung cancer diagnosis. Sci Rep. 2024;14:14797.","journal-title":"Sci Rep"},{"key":"1901_CR13","doi-asserted-by":"publisher","first-page":"101873","DOI":"10.1016\/j.mcp.2022.101873","volume":"66","author":"YJ Kim","year":"2022","unstructured":"Kim YJ, Jeon H, Jeon S, Lee SH, Kim C, Ahn JH, Um H, Woo YJ, Jeong SH, Kim Y, et al. A method for early diagnosis of lung cancer from tumor originated DNA fragments using plasma cfDNA methylome and fragmentome profiles. Mol Cell Probes. 2022;66:101873.","journal-title":"Mol Cell Probes"},{"key":"1901_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13073-023-01280-6","volume":"16","author":"Y Li","year":"2024","unstructured":"Li Y, Xu J, Chen C, Lu Z, Wan D, Li D, Li JS, Sorg AJ, Roberts CC, Mahajan S, et al. Multimodal epigenetic sequencing analysis (MESA) of cell-free DNA for non-invasive colorectal cancer detection. Genome Med. 2024;16:9.","journal-title":"Genome Med"},{"key":"1901_CR15","doi-asserted-by":"publisher","first-page":"618955","DOI":"10.3389\/fgene.2021.618955","volume":"12","author":"SR Hong","year":"2021","unstructured":"Hong SR, Shin KJ. Bisulfite-converted DNA quantity evaluation: a multiplex quantitative real-time PCR system for evaluation of bisulfite conversion. Front Genet. 2021;12:618955.","journal-title":"Front Genet"},{"key":"1901_CR16","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s13148-023-01563-0","volume":"15","author":"SH Kresse","year":"2023","unstructured":"Kresse SH, Brandt-Winge S, Pharo H, Flatin BTB, Jeanmougin M, Vedeld HM, Lind GE. Evaluation of commercial kits for isolation and bisulfite conversion of circulating cell-free tumor DNA from blood. Clin Epigenetics. 2023;15:151.","journal-title":"Clin Epigenetics"},{"key":"1901_CR17","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1080\/15592294.2017.1334024","volume":"12","author":"MBW Orntoft","year":"2017","unstructured":"Orntoft MBW, Jensen SO, Hansen TB, Bramsen JB, Andersen CL. Comparative analysis of 12 different kits for bisulfite conversion of circulating cell-free DNA. Epigenetics. 2017;12:626\u201336.","journal-title":"Epigenetics"},{"key":"1901_CR18","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1002\/cncr.34159","volume":"128","author":"SK Pedersen","year":"2022","unstructured":"Pedersen SK, Musher BL, LaPointe LC, Tuck MK, Symonds EL, Loayza N, Young GP. Detection of recurrent colorectal cancer with high specificity using a reporting threshold for circulating tumor DNA methylated in BCAT1 and IKZF1. Cancer. 2022;128:1921\u20138.","journal-title":"Cancer"},{"key":"1901_CR19","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1186\/s12885-015-1674-2","volume":"15","author":"SK Pedersen","year":"2015","unstructured":"Pedersen SK, Symonds EL, Baker RT, Murray DH, McEvoy A, Van Doorn SC, Mundt MW, Cole SR, Gopalsamy G, Mangira D, et al. Evaluation of an assay for methylated BCAT1 and IKZF1 in plasma for detection of colorectal neoplasia. BMC Cancer. 2015;15:654.","journal-title":"BMC Cancer"},{"key":"1901_CR20","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13073-020-00750-5","volume":"12","author":"F Erger","year":"2020","unstructured":"Erger F, Norling D, Borchert D, Leenen E, Habbig S, Wiesener MS, Bartram MP, Wenzel A, Becker C, Toliat MR, et al. cfNOMe\u2014A single assay for comprehensive epigenetic analyses of cell-free DNA. Genome Med. 2020;12:54.","journal-title":"Genome Med"},{"key":"1901_CR21","doi-asserted-by":"publisher","first-page":"5861","DOI":"10.18632\/oncotarget.14390","volume":"8","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Xu Y, Zhong W, Zhao J, Chen M, Zhang L, Li L, Wang M. Total DNA input is a crucial determinant of the sensitivity of plasma cell-free DNA EGFR mutation detection using droplet digital PCR. Oncotarget. 2017;8:5861\u201373.","journal-title":"Oncotarget"},{"key":"1901_CR22","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.4161\/epi.22191","volume":"7","author":"K Andresen","year":"2012","unstructured":"Andresen K, Boberg KM, Vedeld HM, Honne H, Hektoen M, Wadsworth CA, Clausen OP, Karlsen TH, Foss A, Mathisen O, et al. Novel target genes and a valid biomarker panel identified for cholangiocarcinoma. Epigenetics. 2012;7:1249\u201357.","journal-title":"Epigenetics"},{"key":"1901_CR23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/hep.32125","volume":"75","author":"HM Vedeld","year":"2022","unstructured":"Vedeld HM, Grimsrud MM, Andresen K, Pharo HD, von Seth E, Karlsen TH, Honne H, Paulsen V, Farkkila MA, Bergquist A, et al. Early and accurate detection of cholangiocarcinoma in patients with primary sclerosing cholangitis by methylation markers in bile. Hepatology. 2022;75:59\u201373.","journal-title":"Hepatology"},{"key":"1901_CR24","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1093\/clinchem\/hvaa125","volume":"66","author":"JF Huggett","year":"2020","unstructured":"Group d, Huggett JF. The digital MIQE guidelines update: minimum information for publication of quantitative digital PCR experiments for 2020. Clin Chem. 2020;66:1012\u201329.","journal-title":"Clin Chem"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-025-01901-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-025-01901-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-025-01901-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T04:22:10Z","timestamp":1749010930000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalepigeneticsjournal.biomedcentral.com\/articles\/10.1186\/s13148-025-01901-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1901"],"URL":"https:\/\/doi.org\/10.1186\/s13148-025-01901-4","relation":{},"ISSN":["1868-7083"],"issn-type":[{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]},"assertion":[{"value":"16 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Regional Committee for Medical and Health Research Ethics, South-Eastern Norway (project ID 1.2005.1629 and 2010\/1805). Written informed consent was obtained from all patients, and the study was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"GEL and HP are named on one granted patent (US11555222B2) and one pending US national application (US\/2019\/0221286) covering the 4Plex control and PoDCall algorithm, respectively, used in the present study for normalization of DNA methylation ddPCR results. The remaining authors have nothing to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"93"}}